Bone mineral density in adolescent females using depot medroxyprogesterone acetate.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Pediatric and Adolescent Gynecology

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JPAG.2003.11.017PMID 15010034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of smoking and oral contraceptives on bone mineral density and bone remodeling in young women: a 2-year study.

  2003cited by this paper
• Bone mass of asian adolescents in China: influence of physical activity and smoking.

  2003cited by this paper
• Determinants of Bone Density in 30‐ to 65‐Year‐Old Women: A Co‐Twin Study

  2003cited by this paper
• Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate.

  2002cited by this paper
• Injectable Hormone Contraception and Bone Density: Results from a Prospective Study

  2002cited by this paper
• A Prospective, Controlled Study of the Effects of Hormonal Contraception on Bone Mineral Density

  2001cited by this paper
• Effects of contraceptive use on bone biochemical markers in young women.

  2001cited by this paper
• Adolescents: At Increased Risk for Osteoporosis?

  2000cited by this paper
• Steroid Hormone Contraception and Bone Mineral Density: A Cross‐Sectional Study in an International Population

  2000cited by this paper
• Weight change in adolescents who used hormonal contraception.

  1999cited by this paper
• Forearm bone density in users of Depo-Provera as a contraceptive method.

  1999cited by this paper
• Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.

  1998cited by this paper
• A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.

  1996cited by this paper
• Compliance with contraceptives and other treatments.

  1996cited by this paper
• Relationship between medication compliance and medical outcomes.

  1995cited by this paper
• Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.

  1992cited by this paper
• Changes in vertebral bone density in black girls and white girls during childhood and puberty.

  1991cited by this paper
• Risk of contraceptive discontinuation among adolescents.

  1989cited by this paper

• Menstrual management using hormonal medications in adolescents and young adults with developmental disability: a systematic review and a meta-analysis

  2025cites this paper
• Contraception in Adolescents.

  2024cites this paper
• U.S. Medical Eligibility Criteria for Contraceptive Use, 2024

  2024cites this paper
• Eating Disorders in Children and Adolescents: A Practical Review and Update for Pediatric Gynecologists.

  2021cites this paper
• Bone health and hormonal contraception.

  2021cites this paper
• An endocrine perspective on menstrual suppression for adolescents: achieving good suppression while optimizing bone health

  2021cites this paper
• Changing US trends in contraceptive choices

  2021cites this paper
• Hormonal Contraception and Bone

  2021cites this paper
• Bones and Birth Control in Adolescent Girls.

  2020cites this paper
• Adolescent use of combined hormonal contraception and peak bone mineral density accrual: A meta‐analysis of international prospective controlled studies

  2019cites this paper
• Effects of Estrogen Replacement on Bone Geometry and Microarchitecture in Adolescent and Young Adult Oligoamenorrheic Athletes: A Randomized Trial

  2019cites this paper
• Decreasing trends in number of depot medroxyprogesterone acetate starters in Norway – a cross‐sectional study

  2018cites this paper
• The impact of the boxed warning on the duration of use for depot medroxprogesterone acetate

  2017cites this paper
• Oral and depot progestin therapy for endometriosis: towards a personalized medicine

  2017cites this paper
• Bone mineral density testing, and bisphosphonate and oestrogen prescribing associated with depot medroxyprogesterone acetate utilization—The impact of the boxed warning

  2017cites this paper
• Progestin-Only Contraception and Bone Health

  2017cites this paper
• Bone Mineral Density and Weight Changes in Adolescents Randomized to 3 Doses of Depot Medroxyprogesterone Acetate.

  2017cites this paper
• U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.

  2016influential citation
• Treatment Options for the Adolescent Patient Experiencing Abnormal Uterine Bleeding

  2016cites this paper
• The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations

  2016cites this paper
• Canadian Contraception Consensus (Part 3 of 4): Chapter 8 - Progestin-Only Contraception.

  2016cites this paper
• Consensus canadien sur la contraception (3(e) partie de 4) : chapitre 8 - contraception à progestatif seul.

  2016cites this paper
• Contraception for Adolescents

  2014cites this paper
• Bone Health and Hormonal Contraception

  2014cites this paper
• Contraception for Adolescents abstract Contraception is a pillar in reducing adolescent pregnancy rates

  2014cites this paper
• The approach to chronic pelvic pain in the adolescent.

  2014cites this paper
• Contraception for Adolescents

  2014cites this paper
• Bone mineral density in young adult females using oral contraceptives: a controled prospective study

  2013cites this paper
• Contraception for Adolescents

  2013cites this paper
• Skeletal age estimation and the epiphyseal scar : challenging the status quo

  2013cites this paper
• Contraception and Sterilization

  2012cites this paper
• Menstrual Disorders in Adolescents: Review of Current Practice

  2012cites this paper
• Combined oral contraceptives’ influence on weight, body composition, height, and bone mineral density in girls younger than 18 years: A systematic review

  2012cites this paper
• Contraception and cancer treatment in young persons.

  2012cites this paper
• The Effect of Hormonal Oral Contraception on Acquisition of Peak Bone Mineral Density of Adolescents and Young Women

  2012cites this paper
• Hormonal contraception and bone metabolism: a systematic review.

  2012cites this paper
• Effect of Injectable and Oral Contraceptives on Glucose and Insulin Levels

  2011cites this paper
• Relationship between weight and bone mineral density in adolescents on hormonal contraception.

  2011cites this paper
• Update on hormonal contraception and bone density

  2011cites this paper
• Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation.

  2011cites this paper
• Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.

  2011cites this paper
• Medical eligibility criteria for contraceptive use

  2011cites this paper
• Hormonal contraception and bone mineral density

  2011cites this paper
• Densidade mineral óssea em usuárias e ex-usuárias do contraceptivo injetável com acetato de medroxiprogesterona de depósito

  2011cites this paper
• U.S. Medical Eligibility Criteria for Contraceptive Use, 2010

  2011cites this paper
• Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.

  2010cites this paper
• Is poor nutrition masking the effects of depomedroxyprogesterone acetate on bones in adolescent users?

  2010cites this paper
• Racial difference in lean mass distribution among reproductive-aged women.

  2010cites this paper
• Biopsychosocial variables associated with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate in adolescents: adolescents who lost 5% or more from baseline vs. those who lost less than 5%.

  2010cites this paper
• Predictors of Higher Bone Mineral Density Loss and Use of Depot Medroxyprogesterone Acetate

  2010cites this paper
• Long-term, reversible, progestogenic contraceptive use in adolescents : an evaluation of common hesitations

  2010cites this paper
• Bone mineral density and use of depot medroxyprogesterone acetate (DMPA), norethisterone enanthate (NET-EN) and combined oral contraceptives

  2010influential citation
• Effects of progesterone receptor modulators on human endometrium

  2010cites this paper
• Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study.

  2010cites this paper
• Use of depot medroxyprogesterone acetate and fracture risk.

  2010cites this paper
• Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density.

  2010cites this paper
• The effects of hormonal contraceptives on bone turnover markers and bone health

  2010cites this paper
• Impact de la contraception estroprogestative et progestative sur la densité minérale osseuse Impact of combined and progestogen-only contraceptives on bone mineral density

  2009cites this paper
• DMPA's effect on bone mineral density: A particular concern for adolescents.

  2009cites this paper
• Impact of combined and progestogen-only contraceptives on bone mineral density.

  2009cites this paper
• Menstrual suppression for adolescents with developmental disabilities.

  2009cites this paper
• Puberty, Contraception, and Hormonal Management for Young People With Disabilities

  2009cites this paper
• Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.

  2009cites this paper
• Update in adolescent contraception.

  2009cites this paper
• Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.

  2009influential citation
• Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.

  2009cites this paper
• Hormonal contraception and bone mineral density.

  2009cites this paper
• Impact de la contraception estroprogestative et progestative sur la densité minérale osseuse

  2009cites this paper
• Contraception in women with medical problems

  2008cites this paper
• Hormonal contraception: recent advances and controversies.

  2008cites this paper
• Effects of Depot Medroxyprogesterone Acetate and 20-Microgram Oral Contraceptives on Bone Mineral Density

  2008cites this paper
• Hormonal contraception and HIV-positive women: metabolic concerns and management strategies.

  2008cites this paper
• Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study.

  2008cites this paper
• Hormonal contraception and blood lead levels in inner-city adolescent girls.

  2008cites this paper
• Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.

  2008cites this paper
• Contraception in the under‐16s: issues of confidentiality and choice of methods

  2008cites this paper
• Bone density recovery after depot medroxyprogesterone acetate injectable contraception use.

  2008cites this paper
• PERBANDINGAN DENSITAS MINERAL TULANG PADA PEMAKAI KONTRASEPSI KOMBINASI DENGAN DEPOMEDROKSIPROGESTERON ASETAT UNTUK JANGKA PANJANG DI PUSKESMAS MANDALA MEDAN

  2008cites this paper
• Original research article Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera®) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density ☆

  2008cites this paper
• Effects of Depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: a case-control study.

  2008cites this paper
• Depot-medroxyprogesterone acetate: an update

  2008cites this paper
• Original research article The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women

  2008cites this paper
• Effectiveness of Highly Active Antiretroviral Therapy in HIV-Positive Children: Evaluation at 12 Months in a Routine Program in Cambodia

  2007cites this paper
• Suppression of menstruation in adolescents with severe learning disabilities

  2007cites this paper
• Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception.

  2007cites this paper
• Original research article Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception B

  2007cites this paper
• Hormonal Contraception and Bone Mineral Density

  2007cites this paper
• Does the use of hormonal contraceptives affect bone mineral density

  2007cites this paper
• Endométriose et adolescente

  2006cites this paper
• Bone health in adolescents.

  2006cites this paper
• Bone mineral density and depot medroxyprogesterone acetate.

  2006cites this paper
• Menstrual control in the developmentally delayed adolescent: new treatment options.

  2006cites this paper
• Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

  2006cites this paper
• Depot Medroxyprogesterone Acetate, Oral Contraceptives and Bone Mineral Density in a Cohort of Adolescent Girls

  2006cites this paper
• Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.

  2006cites this paper
• Consensus canadien sur la contraception—Mise à jour sur l’acétate de médroxyprogestérone-retard (AMPR)

  2006cites this paper
• Sexuality of Children and Adolescents With Developmental Disabilities

  2006cites this paper
• Hormonal Contraception in Adolescents

  2006cites this paper
• The adolescent gynecology patient

  2006cites this paper
• Hormonal contraception in adolescents: special considerations.

  2006cites this paper